Page Views: 66 Date Added: 09/14/2011 Last Updated: 09/14/2011 Expiry Date: 09/11/2021 Product/Service Details Seabuckthorn oil soft capsule Indications: 1.Hyperlipemia 2.Hypercholesterolemia 3.Duodenitis 3.Ulcer Using CO2 supercritical extraction technology, the product can maintain the originalbiological activity, the product does not contain any harmful substances and residualsolvent, the product of high purity, good quality, high absorption rate. Pharmaceutical value: 1.Fructus Hippophae inhalans drug for a long time, its health care effects are generally accepted by people. Seabuckthorm Seed Oil contains abundant ω-3 unsaturated fatty acid, phytosterols, lecithin, vitamin E and other bioactivity substance, ω-3 unsaturated fatty acid conduce to remove cholesterol of blood, also decrease redundant fat of liver, improve fatty liver and increase liver function. 2.In addition, Seabuckthorm Seed Oil contains abundant phytosterols, phytosterols in human body intestinal tract combine with acceptor of intestinal tract, competitively restrain absorption of intestinal tract to cholesterol, decrease blood fat and protect liver. Seabuckthorm Seed Oil also contains phosphatides, phosphatides obtain the affirmation of the world medicine educational circles by protecting liver, the bilineurine of phosphatides has affinity to fat, if internal bilineurine is not enough and influence fat lipometabolism, cause fat to accumulate in liver, form fatty liver and even inflammation tumescence. Phosphatides not only prevent fatty liver, but also promote liver cell regeneration, prevent liver cirrhosis and conduce to recover liver function. Vitamin E is a notable antioxidant, decrease LPO, reduce cellular attack by free radicals, conduce to liver cellular health.

Company Information (Xiuzheng Pharmaceutical Group International Trading CO.,LTD)

Company Profile: Xiuzheng Pharmaceutical Group, founded in 1995 by the chairman of the board Mr. XiuLaigui, is one of the largest modern pharmaceutical enterprises in China, which is dedicated to R&D, manufacturing and marketing of Chinese traditional medicine, chemical medicine and biological medicine worldwide. Xiuzheng also owns a chain drugstore and planting bases focusing on standardized planting and processing of herbs. The architect of developing Xiuzheng is formed by One national class enterprise technical center, Five bases for raw medical material, Eight pharmaceutical bases and Fifteen sales systems. Xiuzheng had 45 wholly-owned subsidiaries, over 60,000 employees and total assets of 14.2 billion yuan. Xiuzheng ranked the 1st among the pharmaceutical enterprises of Jilin province from 2000 to 2007, and was No.1 in the profit ranking of traditional Chinese medicine enterprises in 2004. The total sales income of Xiuzheng has exceeded 20 billion yuan, with total amount of tax paid over 1.1 billion yuan and a profit of 2.95 billion yuan by 2007. In 2007, the sales income of Xiuzheng exceeded 5.7 billion yuan. In 2008, the total output value of Xiuzheng exceeded 7.9 billion yuan with 7.6 billion yuan of sales income and 600 million yuan of total pre-tax profits, In 2010, the sales income of Xiuzheng exceeded 18 billion yuan,heading the list of national pharmaceutical enterprises. Xiuzheng now manufactures more than 800 different drugs and pharmaceuticals and about 1,000 health care products. The brands of Xiuzheng and Sidashu win the honor of Chinese Well-Known Marks. By now Xiuzheng has awarded hundreds of honors such as the National Contract-honoring, the Promise-keeping Enterprise, the National Torch Plan Project Superior Hi-tech Enterprise and the National Scientific and Technological Innovation Spark Plan Leading Enterprise, etc. Xiuzheng has a national enterprise technical center, a national engineering center and a post-doctoral workstation, with more than 500 technical personnel, many of whom are qualified with senior professional titles. Xiuzheng also established long-term cooperation with universities and research institutions to further upgrading the capabilities in pharmaceutical research and development. Xiuzheng also cares much about charity work and public welfare work, and has so far donated more than 350 million yuan and supplies over 60,000 job opportunities for the society. Xiuzheng is aiming at being the best pharmaceutical enterprise in China and plans to achieve more than 25 billion yuan of sales income in 2011.. >> More Website URL: http://www.bridgat.com/u44913